Intrinsic Value of S&P & Nasdaq Contact Us

Envista Holdings Corp NVST NYSE

NYSE • Healthcare • Medical - Equipment & Services • US • USD

SharesGrow Score
43/100
0/7 Pass
SharesGrow Intrinsic Value
$19.72
-28%
Analyst Price Target
$27.22
-0.6%

Envista Holdings Corp (NVST) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 7 Buy, 11 Hold, 1 Sell.

The consensus price target is $27.22 (low: $19.00, high: $35.00), representing a downside of 0.6% from the current price $27.38.

Analysts estimate Earnings Per Share (EPS) of $0.71 and revenue of $2.50B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-6.50 vs est $0.71 (missed -1009.3%). 2025: actual $0.28 vs est $1.15 (missed -75.5%). Analyst accuracy: 0%.

NVST Stock — 12-Month Price Forecast

$27.22
▼ -0.58% Downside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for Envista Holdings Corp, the average price target is $27.22, with a high forecast of $35.00, and a low forecast of $19.00.
The average price target represents a -0.58% change from the last price of $27.38.
Highest Price Target
$35.00
Average Price Target
$27.22
Lowest Price Target
$19.00

NVST Analyst Ratings

Hold
19
Ratings
7 Buy
11 Hold
1 Sell
Based on 19 analysts giving stock ratings to Envista Holdings Corp in the past 3 months
Rating breakdown
Buy
7 37%
Hold
11 58%
Sell
1 5%
37%
Buy
7 analysts
58%
Hold
11 analysts
5%
Sell
1 analysts

EPS Estimates — NVST

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$6.50 vs Est $0.71 ▼ 111.0% off
2025 Actual $0.28 vs Est $1.15 ▼ 308.9% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — NVST

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $2.511B vs Est $2.504B ▲ 0.3% off
2025 Actual $2.720B vs Est $2.645B ▲ 2.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message